文献速递腹部US

血管后期闪烁成像在丙型肝炎病毒相关肝病进展评估中的应用价值

Flash Imaging Used in the Post-vascular Phase of Contrast-Enhanced Ultrasonography is Useful for Assessing the Progression in Patients with Hepatitis C Virus-Related Liver Disease.
PubMed 文献 · Ultrasound Med Biol · 2019-04-25

研究纳入2007至2017年409例丙型肝炎病毒相关肝病患者,在Sonazoid血管后期(注射后10分钟)行闪烁成像破坏微泡并测量破坏范围。259例肝活检患者中,微泡破坏范围随纤维化分期进展而显著增大(F0-1 42.0±10.4 mm、F2 42.9±13.2 mm、F3 51.5±15.9 mm、F4 55.4±17.3 mm),且与Vs、总胆红素、FIB4指数正相关,与白蛋白、血小板计数、凝血酶原时间负相关。结果表明该方法可无创预测肝病进展。

要点

  • Sonazoid血管后期闪烁成像测量的微泡破坏范围随肝纤维化分期进展而增大。
  • 微泡破坏范围与Vs、FIB4指数呈正相关,与白蛋白、血小板、凝血酶原时间负相关。
  • 该方法为无创评估丙型肝炎病毒相关肝病进展的潜在手段。

核心结论

  • 血管后期闪烁成像可无创预测丙型肝炎病毒相关肝病患者的疾病进展。

研究设计与样本

  • 研究纳入2007至2017年409例丙型肝炎病毒相关肝病患者(男205例、女204例,平均年龄60±14岁,范围20-90岁);其中259例有肝活检纤维化分期,150例肝硬化基于影像学诊断。

关键影像表现/征象

  • 注射Sonazoid后10分钟血管后期行闪烁成像破坏肝实质内微泡,测量自肝表面的微泡破坏范围。

诊断标准与关键数值

  • 微泡破坏范围:F0-1期42.0±10.4 mm,F2期42.9±13.2 mm,F3期51.5±15.9 mm,F4期55.4±17.3 mm,随纤维化分期进展显著增大。
  • 微泡破坏范围与Vs正相关(r=0.34,p<0.01)、与总胆红素正相关(r=0.25,p<0.01)、与FIB4指数正相关(r=0.38,p<0.01)。
  • 微泡破坏范围与白蛋白负相关(r=-0.34,p<0.01)、与血小板计数负相关(r=-0.35,p<0.01)、与凝血酶原时间负相关(r=-0.36,p<0.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Sonazoid is a commonly used contrast agent for characterizing liver tumors in ultrasonography (US). We performed flash imaging in the post-vascular phase of contrast-enhanced US (CEUS) to investigate associations between collapse of Sonazoid microbubbles (MB) and progression of liver disease. This study enrolled 409 patients (205 men, 204 women) with hepatitis C virus-related liver disease (CLD) between 2007 and 2017 (mean age 60 ± 14 y; range 20-90 y). In the post-vascular phase, 10 min after administering Sonazoid, flash imaging was performed to burst MB in the liver parenchyma; the range of bubble destruction was measured from the surface of the liver. The range of bubble destruction, stage of fibrosis, shear wave velocity (Vs), serologic markers and fibrosis-4 (FIB4) index were analyzed in 259 patients who underwent liver biopsy. Fibrosis stage was F0-1 in 108 patients, F2 in 73, F3 in 38 and F4 in 40. In 150 patients with cirrhosis, diagnosis was made based on imaging findings. The range of bubble destruction was 42.0 ± 10.4 mm in F0-1 patients, 42.9 ± 13.2 mm in F2, 51.5 ± 15.9 mm in F3 and 55.4 ± 17.3 mm in F4 and was significantly increased according to progression of fibrosis staging. The range of bubble destruction was positively correlated with Vs (r = 0.34; p < 0.01), total bilirubin (r = 0.25; p < 0.01) and FIB4 index (r = 0.38; p < 0.01). In contrast, the range of bubble destruction was negatively correlated with serum levels of albumin (r = -0.34; p < 0.01), platelet count (r = -0.35; p < 0.01) and prothrombin time (r = -0.36; p < 0.01). The results indicated that flash imaging in the post-vascular phase of CEUS was a non-invasive assessment and could predict disease progression in patients with CLD.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Wakui N, Nagai H, Yoshimine N, et al. Flash Imaging Used in the Post-vascular Phase of Contrast-Enhanced Ultrasonography is Useful for Assessing the Progression in Patients with Hepatitis C Virus-Related Liver Disease. Ultrasound Med Biol. 2019. PMID: 31031037. doi:10.1016/j.ultrasmedbio.2019.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。